General knowledge
Explore, Learn, Apply
Delve into our collection of papers, where we share the latest research and applications related to our products and services. These papers offer a blend of current findings and practical benefits, providing in-depth analysis and insights into advancements in this sector. Whether you’re looking to understand emerging trends or apply cutting-edge techniques in your work, these papers serve as a valuable resource for both academic and practical understanding.
Emulseo takes part actively to the race against cancer by providing chemical formulations for droplet-based microfluidic applications enabling early cancer detection, patient follow-up and personalized cancer treatment. The last decade, huge breakthroughs in cancer diagnosis have been accomplished with the emergence of liquid biopsy. Droplet-based microfluidic technology has been instrumental in these progresses…
Droplet-based microfluidics is a highly sensitive, fast and accurate technology with a high potential for automation. Therefore, this is a powerful and very promising tool for research on antibiotic resistance of bacteria. Its versatility makes it suitable for every step of antibiotic discovery and development…
How droplet-based microfluidics can play a key role in cancer treatment research? Droplet-based microfluidics can be used to create multicellular tumor spheroids (MCTSs), that are a very powerful tool to mimic in vivo solid tumors. MCTSs can simply be described as aggregates of cancer cells, thus forming a three-dimensional (3D) tumor model…
Certificates of Analysis (CoAs) represent an essential component of our commitment to the quality and transparency of our products. As a detailed document attesting to the characteristics and compliance of our products for a large range of microfluidic applications, CoAs play a crucial role in ensuring customer satisfaction and preserving our reputation…
Click here to download the FluoSurf™ dilution protocol. If you have any questions, don’t hesitate to contact our team of experts.